Effect of troglitazone on lipoprotein(a) levels in obese subjects.
Tack
C J
CJ
Smits
P
P
DeMacker
P N
PN
Stalenhoef
A F
AF
D002839:Chromans / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance; D017270:Lipoprotein(a) / Q000097:blood*; D009765:Obesity; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D017270:Lipoprotein(a); D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone